SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-23-060847
Filing Date
2023-03-06
Accepted
2023-03-06 09:24:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d444958dsc14d9a.htm SC 14D9/A 18393
  Complete submission text file 0001193125-23-060847.txt   20283
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filed by) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Subject) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-89626 | Film No.: 23707777
SIC: 2834 Pharmaceutical Preparations